Modeling transmission dynamics and control of vector-borne neglected tropical diseases.

PubWeight™: 1.02‹?› | Rank: Top 15%

🔗 View Article (PMC 2964290)

Published in PLoS Negl Trop Dis on October 26, 2010

Authors

Paula M Luz1, Claudio J Struchiner, Alison P Galvani

Author Affiliations

1: School of Public Health, Yale University, New Haven, Connecticut, USA. paula.luz@ipec.fiocruz.br

Articles cited by this

Control of neglected tropical diseases. N Engl J Med (2007) 14.49

Uses and abuses of mathematics in biology. Science (2004) 5.24

The ecology of genetically diverse infections. Science (2001) 4.37

Modeling household transmission of American trypanosomiasis. Science (2001) 3.48

A model of the transmission of dengue fever with an evaluation of the impact of ultra-low volume (ULV) insecticide applications on dengue epidemics. Am J Trop Med Hyg (1992) 3.00

Malaria control with genetically manipulated insect vectors. Science (2002) 2.96

Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum. Proc Natl Acad Sci U S A (2007) 2.72

Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci U S A (2003) 2.45

Mathematical models of infectious disease transmission. Nat Rev Microbiol (2008) 2.32

Mathematics is biology's next microscope, only better; biology is mathematics' next physics, only better. PLoS Biol (2004) 2.24

Mathematical modelling and the control of lymphatic filariasis. Lancet Infect Dis (2004) 2.13

Towards a global dengue research agenda. Trop Med Int Health (2007) 2.01

Evolving public perceptions and stability in vaccine uptake. Math Biosci (2006) 1.96

Mosquitoes do senesce: departure from the paradigm of constant mortality. Am J Trop Med Hyg (2007) 1.95

Yellow fever vaccination: how much is enough? Vaccine (2005) 1.89

Modelling the control strategies against dengue in Singapore. Epidemiol Infect (2007) 1.86

Assessing the effect of natural selection in malaria parasites. Trends Parasitol (2004) 1.78

Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A (2009) 1.76

Insecticide resistance mechanisms of Brazilian Aedes aegypti populations from 2001 to 2004. Am J Trop Med Hyg (2007) 1.65

Genetic polymorphism and molecular epidemiology of Leishmania (Viannia) braziliensis from different hosts and geographic areas in Brazil. J Clin Microbiol (2003) 1.59

Cost-effectiveness of annual targeted larviciding campaigns in Cambodia against the dengue vector Aedes aegypti. Trop Med Int Health (2007) 1.57

Uncertainties regarding dengue modeling in Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz (2003) 1.51

Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. Stat Med (1999) 1.47

Important experimental parameters for determining infection rates in arthropod vectors using pool screening approaches. Am J Trop Med Hyg (2006) 1.43

Potential for integrated control of neglected tropical diseases in Ethiopia. Trans R Soc Trop Med Hyg (2007) 1.40

EPIFIL: the development of an age-structured model for describing the transmission dynamics and control of lymphatic filariasis. Epidemiol Infect (2000) 1.27

Cost-effectiveness of chagas disease vector control strategies in Northwestern Argentina. PLoS Negl Trop Dis (2009) 1.20

Cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis. Bull World Health Organ (1999) 1.16

Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Trop Med Int Health (2007) 1.14

Impact of residual spraying on Rhodnius prolixus and Triatoma dimidiata in the department of Zacapa in Guatemala. Mem Inst Oswaldo Cruz (2003) 1.13

Simulation as experiment: a philosophical reassessment for biological modeling. Trends Ecol Evol (2004) 1.08

Risk of fatal adverse events associated with 17DD yellow fever vaccine. Epidemiol Infect (2004) 1.06

Macrofilaricides and onchocerciasis control, mathematical modelling of the prospects for elimination. BMC Public Health (2001) 1.06

Impact of insecticide interventions on the abundance and resistance profile of Aedes aegypti. Epidemiol Infect (2009) 1.03

Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface (2007) 1.03

The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat (2009) 1.01

Evolutionary ideas about genetically manipulated mosquitoes and malaria control. Trends Parasitol (2003) 1.00

Antibiotic and insecticide resistance modeling--is it time to start talking? Trends Microbiol (2001) 0.90

Uncertainty and sensitivity analyses of a dynamic economic evaluation model for vaccination programs. Med Decis Making (2008) 0.83

Seasonal population dynamics and behaviour of insects in models of vector-borne pathogens. Physiol Entomol (2004) 0.83

Modeling and biological control of mosquitoes. J Am Mosq Control Assoc (2007) 0.81

Modeling targeted ivermectin treatment for controlling river blindness. Am J Trop Med Hyg (2006) 0.81

Articles by these authors

Ecological and immunological determinants of influenza evolution. Nature (2003) 7.60

Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis (2009) 6.81

Optimizing influenza vaccine distribution. Science (2009) 4.37

Effect of Ebola progression on transmission and control in Liberia. Ann Intern Med (2014) 3.96

Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study. Lancet (2007) 3.65

Genome sequences of the human body louse and its primary endosymbiont provide insights into the permanent parasitic lifestyle. Proc Natl Acad Sci U S A (2010) 2.76

Epidemiology: dimensions of superspreading. Nature (2005) 2.47

Group interest versus self-interest in smallpox vaccination policy. Proc Natl Acad Sci U S A (2003) 2.45

Dengue vector control strategies in an urban setting: an economic modelling assessment. Lancet (2011) 2.24

Time series analysis of dengue incidence in Rio de Janeiro, Brazil. Am J Trop Med Hyg (2008) 2.05

Curtailing transmission of severe acute respiratory syndrome within a community and its hospital. Proc Biol Sci (2003) 2.02

Evolving public perceptions and stability in vaccine uptake. Math Biosci (2006) 1.96

Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A (2009) 1.76

Dynamically modeling SARS and other newly emerging respiratory illnesses: past, present, and future. Epidemiology (2005) 1.75

Cost-effectiveness of genotype testing for primary resistance in Brazil. J Acquir Immune Defic Syndr (2015) 1.73

Cost-effectiveness of canine vaccination to prevent human rabies in rural Tanzania. Ann Intern Med (2014) 1.73

Epidemiology. Social factors in epidemiology. Science (2013) 1.71

Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis (2016) 1.70

Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low? Lancet Infect Dis (2010) 1.65

Ebola vaccination: if not now, when? Ann Intern Med (2014) 1.57

The geographic spread of the CCR5 Delta32 HIV-resistance allele. PLoS Biol (2005) 1.46

Evaluating the cost-effectiveness of rabies post-exposure prophylaxis: a case study in Tanzania. Vaccine (2009) 1.28

Self-reported skin color, genomic ancestry and the distribution of GST polymorphisms. Pharmacogenet Genomics (2007) 1.28

Vector host-feeding preferences drive transmission of multi-host pathogens: West Nile virus as a model system. Proc Biol Sci (2011) 1.24

A general approach for population games with application to vaccination. Math Biosci (2011) 1.24

Integrating epidemiology, psychology, and economics to achieve HPV vaccination targets. Proc Natl Acad Sci U S A (2008) 1.22

The dynamics of risk perceptions and precautionary behavior in response to 2009 (H1N1) pandemic influenza. BMC Infect Dis (2010) 1.20

Potential for rabies control through dog vaccination in wildlife-abundant communities of Tanzania. PLoS Negl Trop Dis (2012) 1.10

Vaccination against multiple HPV types. Math Biosci (2005) 1.09

Infections with immunogenic trypanosomes reduce tsetse reproductive fitness: potential impact of different parasite strains on vector population structure. PLoS Negl Trop Dis (2008) 1.09

How host heterogeneity governs tuberculosis reinfection? Proc Biol Sci (2012) 1.08

The impact of imitation on vaccination behavior in social contact networks. PLoS Comput Biol (2012) 1.07

Erratic flu vaccination emerges from short-sighted behavior in contact networks. PLoS Comput Biol (2011) 1.07

The influence of altruism on influenza vaccination decisions. J R Soc Interface (2012) 1.07

The effect of treatment on pathogen virulence. J Theor Biol (2004) 1.06

Immune status at presentation for HIV clinical care in Rio de Janeiro and Baltimore. J Acquir Immune Defic Syndr (2011) 1.04

Evaluating candidate agents of selective pressure for cystic fibrosis. J R Soc Interface (2007) 1.04

The ethics of influenza vaccination. Science (2006) 1.04

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination. Vaccine (2009) 1.04

Vaccinating to help ourselves and others. Med Decis Making (2011) 1.03

Vaccinating in disease-free regions: a vaccine model with application to yellow fever. J R Soc Interface (2007) 1.03

Epidemiological game-theory dynamics of chickenpox vaccination in the USA and Israel. J R Soc Interface (2011) 1.01

Glossina fuscipes populations provide insights for human African trypanosomiasis transmission in Uganda. Trends Parasitol (2013) 1.01

The impact of transgenic mosquitoes on dengue virulence to humans and mosquitoes. Am Nat (2009) 1.01

When does overuse of antibiotics become a tragedy of the commons? PLoS One (2012) 0.99

Optimal timing of disease transmission in an age-structured population. Bull Math Biol (2007) 0.98

Associations between defined polymorphic variants in the PfRH ligand family and the invasion pathways used by P. falciparum field isolates from Brazil. Mol Biochem Parasitol (2006) 0.98

The cost-effectiveness of pentavalent rotavirus vaccination in England and Wales. Vaccine (2012) 0.97

Impact of rotavirus vaccination on epidemiological dynamics in England and Wales. Vaccine (2011) 0.96

Using game theory to examine incentives in influenza vaccination behavior. Psychol Sci (2012) 0.94

In vitro-reduced susceptibility to artemether in P. falciparum and its association with polymorphisms on transporter genes. J Infect Dis (2012) 0.94

The theoretical influence of immunity between strain groups on the progression of drug-resistant tuberculosis epidemics. J Infect Dis (2008) 0.93

Pharmacogenomic implications of population admixture: Brazil as a model case. Pharmacogenomics (2014) 0.93

Viral load and CD4 count dynamics after HIV-1 seroconversion in homosexual and bisexual men in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr (2006) 0.92

Evolutionary repercussions of avian culling on host resistance and influenza virulence. PLoS One (2009) 0.92

Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types. J Infect Dis (2012) 0.91

Distinguishing vaccine efficacy and effectiveness. Vaccine (2012) 0.91

Decision making with regard to antiviral intervention during an influenza pandemic. Med Decis Making (2010) 0.90

Pharmacogenetics of calcineurin inhibitors in Brazilian renal transplant patients. Pharmacogenomics (2011) 0.90

Dengue dynamics and vaccine cost-effectiveness in Brazil. Vaccine (2013) 0.89

Evaluating paratransgenesis as a potential control strategy for African trypanosomiasis. PLoS Negl Trop Dis (2013) 0.88

Direct and indirect effects of rotavirus vaccination: comparing predictions from transmission dynamic models. PLoS One (2012) 0.87

The epidemiological impact of HIV antiretroviral therapy on malaria in children. AIDS (2015) 0.87

Optimal H1N1 vaccination strategies based on self-interest versus group interest. BMC Public Health (2011) 0.87

Interrupting Ebola Transmission in Liberia Through Community-Based Initiatives. Ann Intern Med (2016) 0.86

Relative contribution of VKORC1, CYP2C9, and INR response to warfarin stable dose. Blood (2009) 0.86

Cost-effectiveness of a community-based intervention for reducing the transmission of Schistosoma haematobium and HIV in Africa. Proc Natl Acad Sci U S A (2013) 0.85

Time for change? An economic evaluation of integrated cervical screening and HPV immunization programs in Canada. Vaccine (2011) 0.85

Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women. PLoS Negl Trop Dis (2013) 0.84

The evolution of tuberculosis virulence. Bull Math Biol (2009) 0.84

Extensively drug-resistant tuberculosis in South Africa. Lancet (2007) 0.84

Optimal targeting of seasonal influenza vaccination toward younger ages is robust to parameter uncertainty. Vaccine (2013) 0.83

Preferences for HPV vaccination in parent-child dyads: Similarities and acknowledged differences. Prev Med (2011) 0.83

Vaccination and the evolutionary ecology of human papillomavirus. Vaccine (2008) 0.83

Random-effects models in investigating the effect of vitamin A in childhood diarrhea. Ann Epidemiol (2005) 0.83

Re: "Multiparameter calibration of a natural history model of cervical cancer". Am J Epidemiol (2007) 0.83

Cost-Effectiveness of Pertussis Vaccination During Pregnancy in the United States. Am J Epidemiol (2016) 0.83

Predicted outcomes of vaccinating wildlife to reduce human risk of Lyme disease. Vector Borne Zoonotic Dis (2012) 0.82

Modeling targeted ivermectin treatment for controlling river blindness. Am J Trop Med Hyg (2006) 0.81

How do people value life? Psychol Sci (2009) 0.79

Impact of program scale and indirect effects on the cost-effectiveness of vaccination programs. Med Decis Making (2012) 0.79

A model of spatial epidemic spread when individuals move within overlapping home ranges. Bull Math Biol (2006) 0.79

A negative correlation between dengue and bushfires in Brazil. J Environ Health (2014) 0.79

Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strains. PLoS One (2012) 0.79

A marginal benefit approach for vaccinating influenza "superspreaders". Med Decis Making (2014) 0.78

Using network models to approximate spatial point-process models. Math Biosci (2003) 0.78

The estimated magnitude of AIDS in Brazil: a delay correction applied to cases with lost dates. Cad Saude Publica (2002) 0.78

Impact of imitation processes on the effectiveness of ring vaccination. Bull Math Biol (2011) 0.77

Single nucleotide polymorphism coverage and inference of N-acetyltransferase-2 acetylator phenotypes in wordwide population groups. Pharmacogenet Genomics (2016) 0.77

Epidemiological mechanisms of genetic resistance to kuru. J R Soc Interface (2013) 0.75

Optimizing distribution of pandemic influenza antiviral drugs. Emerg Infect Dis (2015) 0.75

Correction: Harnessing Case Isolation and Ring Vaccination to Control Ebola. PLoS Negl Trop Dis (2015) 0.75

Effect of Ebola progression in Liberia. Ann Intern Med (2015) 0.75

Quantifying Transmission of Clostridium difficile within and outside Healthcare Settings. Emerg Infect Dis (2016) 0.75

Economic epidemiology of avian influenza on smallholder poultry farms. Theor Popul Biol (2013) 0.75

Estimating the genetic component (RGC) in pharmacokinetic variability of the antiretroviral didanosine among healthy Brazilians. AIDS (2005) 0.75

Differential effects of predictors of warfarin dose according to race/color categories in the admixed Brazilian population. Pharmacogenet Genomics (2017) 0.75

The impact of syringe services program closure on the risk of rebound HIV outbreaks among people who inject drugs: A modeling study. AIDS (2022) 0.75